Clinical Trial Update: Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2a clinical trial of TZ-161 for acute spinal cord injury is currently recruiting to evaluate safety, tolerability, and early efficacy signals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• TZ-161

Snippet

Sponsor: Technophage, SA | Conditions: Acute Spinal Cord Injury (SCI) | Phase 1, Phase 2 | Status: RECRUITING